Form 4: TransDigm Group Director Valladares Exercises Options and Sells Shares
SEC Form 4 Filing
Director Jorge Valladares exercised stock options and sold shares of TransDigm Group INC on February 26, 2024, according to a Form 4 filing with the SEC.
Summary
- On February 26, 2024, Jorge Valladares, a director of TransDigm Group INC, exercised stock options to acquire 2,427 shares of common stock at a price of $226.34 per share.
- Simultaneously, Valladares sold a total of 2,427 shares held indirectly through The Jacob Valladares Gift Trust dated October 30, 2020.
- The sales were executed in multiple transactions at varying prices ranging from $1,188.00 to $1,195.8350 per share.
- Following these transactions, The Jacob Valladares Gift Trust continues to beneficially own 1,773 derivative securities (stock options) and no common stock.
Sentiment
Score: 5
Explanation: This is a neutral disclosure of insider trading activity. It doesn't inherently indicate positive or negative sentiment about the company's prospects.
Industry Context
This filing is a routine disclosure of insider transactions and provides insight into the actions of company directors regarding their holdings in the company. It is common for directors to exercise stock options and sell shares for personal financial management.
Key Dates
| Date | Description |
|---|---|
| October 30, 2020 | Date of The Jacob Valladares Gift Trust |
| September 30, 2016 | Date of Stock Option |
| February 26, 2024 | Date of transaction (exercise of options and sale of shares) |
| November 05, 2025 | Expiration date of Stock Option |
| February 28, 2024 | Date of signature on the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.